• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SPECTRANETICS STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON; DCB PTA CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SPECTRANETICS STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON; DCB PTA CATHETER Back to Search Results
Model Number A35SX040120135
Device Problem Insufficient Information (3190)
Patient Problem Vascular Dissection (3160)
Event Date 11/07/2017
Event Type  Injury  
Manufacturer Narrative
Dissection and thrombus were observed during use of the stellarex device.Additional intervention was required to treat the patient, thus resulted in a prolonged procedure.Stellarex 0.035 otw drug-coated angioplasty balloon, paclitaxel drug, 3.3 mg, therapy date: (b)(6) 2017, the stellarex balloon is indicated for the treatment of de-novo or re-stenotic lesions in the lower extremities to establish blood flow and to maintain vessel patency.Lot #: fcw17c23a, expiration date: 04/19/2019, (b)(4).(b)(6).Pma number is not applicable.The device is commercial product with a ce mark./ combination product is applicable the device was disposed, thus no product evaluation was performed.Per the ifu, vessel dissection and thrombosis are listed as potential complications/adverse events of the procedure.
 
Event Description
The patient had small caliber vessels and given 5000 iv heparin.Ballooned with 4 mm stellarex in the sfa and extensive dissection was noted.The dissection was treated with stents.Thrombus was lodged in the tibial vessel btk.The thrombosis was treated with thrombectomy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON
Type of Device
DCB PTA CATHETER
Manufacturer (Section D)
SPECTRANETICS
fremont CA
Manufacturer (Section G)
SPECTRANETICS
6531 dumbarton circle
fremont CA 94555
Manufacturer Contact
florie cazem
5055 brandin court
fremont, CA 94538
510933-792
MDR Report Key7102993
MDR Text Key94357124
Report Number3009784280-2017-00091
Device Sequence Number1
Product Code ONU
Combination Product (y/n)N
Reporter Country CodeUK
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/09/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/19/2019
Device Model NumberA35SX040120135
Device Catalogue NumberA35SX040120135
Device Lot NumberFCW17C23A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/09/2017
Initial Date FDA Received12/10/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/19/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age55 YR
Patient Weight62
-
-